Novo Seven 2mg (Eptacog Alfa (Activated ) Vials) 2mg

Novo Seven 2mg contains Eptacog Alfa (Activated), a coagulation factor VIIa used to manage bleeding episodes in patients with hemophilia. This vial form is stored between 15-25°C and is designed for rapid hemostatic response. Ideal for emergency bleeding control in hemophilia patients. Novo Seven 2mg is a critical treatment option for bleeding disorders.

Strength

2mg

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Novo Nordisk A/S

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Novo Seven 2mg is used to treat bleeding episodes in patients with hemophilia A or B who have inhibitors to factor VIII or factor IX. It is also indicated for congenital factor VII deficiency and Glanzmann’s thrombasthenia. This medication works by promoting blood clotting at the site of bleeding. Patients with these conditions often require prompt treatment to prevent complications.

Side Effects

Novo Seven 2mg helps restore normal clotting function by activating the coagulation cascade where bleeding occurs. Users may experience relief from active bleeding episodes shortly after administration. Some patients report reduced bruising or prolonged bleeding episodes after treatment. The effects vary based on the severity of the bleeding and individual response.

Precautions & Warnings

Novo Seven 2mg should be handled with care to avoid contamination or improper storage. Keep vials at room temperature (15-25°C) and protect from light. Do not use if the solution is discolored or contains particles. Always follow healthcare provider instructions for administration. Patients should report any unusual reactions immediately.

Avoid Interactions

Novo Seven 2mg may interact with medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Caution is advised when used alongside other hemostatic agents. Alcohol and certain herbal supplements may also influence clotting function. Always inform healthcare providers about all medications being taken.

Frequently Asked Questions

Novo Seven 2mg is used to treat bleeding episodes in patients with hemophilia A or B who have inhibitors, congenital factor VII deficiency, or Glanzmann’s thrombasthenia.

Store Novo Seven 2mg vials at room temperature between 15-25°C and protect from light.

Novo Seven 2mg is specifically for bleeding episodes in patients with certain clotting disorders, not for general bleeding or other conditions.

Common effects may include reactions at the injection site or mild allergic responses; report any unusual symptoms to a healthcare provider.

Consult a healthcare provider before using Novo Seven 2mg if pregnant or breastfeeding, as safety varies by individual.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.